Helen Torley Halozyme Therapeutics, Inc. (HALO) insider trading activity

HALO Quotes by TradingView

Helen Torley is PRESIDENT AND CEO of HALOZYME THERAPEUTICS, INC.. Currently has a direct ownership of 733,719 shares of HALO, which is worth approximately $43.4 Million. The most recent transaction as insider was on Aug 14, 2024, when has been sold 10,000 shares (Common Stock) at a price of $57.37 per share, resulting in proceeds of $573,700. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 734K
10.05% 3M change
8.42% 12M change
Total Value Held $43.4 Million

Helen Torley Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 14 2024
SELL
Open market or private sale
$573,700 $57.37 p/Share
10,000 Reduced 1.46%
676,744 Common Stock
Aug 14 2024
BUY
Exercise of conversion of derivative security
$138,700 $13.87 p/Share
10,000 Added 1.44%
686,744 Common Stock
Aug 13 2024
SELL
Open market or private sale
$562,500 $56.25 p/Share
10,000 Reduced 1.46%
676,744 Common Stock
Aug 13 2024
BUY
Exercise of conversion of derivative security
$138,700 $13.87 p/Share
10,000 Added 1.44%
686,744 Common Stock
Feb 16 2024
SELL
Payment of exercise price or tax liability
$735,068 $36.1 p/Share
20,362 Reduced 2.92%
676,744 Common Stock
Feb 16 2024
BUY
Exercise of conversion of derivative security
-
37,884 Added 5.23%
685,814 Common Stock
Feb 15 2024
SELL
Payment of exercise price or tax liability
$885,361 $35.91 p/Share
24,655 Reduced 3.61%
659,222 Common Stock
Feb 15 2024
BUY
Grant, award, or other acquisition
-
32,781 Added 4.62%
676,841 Common Stock
Feb 15 2024
BUY
Exercise of conversion of derivative security
-
13,092 Added 1.97%
651,096 Common Stock
Feb 10 2024
SELL
Payment of exercise price or tax liability
$601,307 $35.49 p/Share
16,943 Reduced 2.59%
638,004 Common Stock
Feb 10 2024
BUY
Exercise of conversion of derivative security
-
31,281 Added 4.56%
654,947 Common Stock
Aug 31 2023
SELL
Open market or private sale
$428,200 $42.82 p/Share
10,000 Reduced 1.58%
623,666 Common Stock
Aug 31 2023
BUY
Exercise of conversion of derivative security
$138,700 $13.87 p/Share
10,000 Added 1.55%
633,666 Common Stock
Aug 30 2023
SELL
Open market or private sale
$428,500 $42.85 p/Share
10,000 Reduced 1.58%
623,666 Common Stock
Aug 30 2023
BUY
Exercise of conversion of derivative security
$138,700 $13.87 p/Share
10,000 Added 1.55%
633,666 Common Stock
Aug 29 2023
SELL
Open market or private sale
$424,000 $42.4 p/Share
10,000 Reduced 1.58%
623,666 Common Stock
Aug 29 2023
BUY
Exercise of conversion of derivative security
$138,700 $13.87 p/Share
10,000 Added 1.55%
633,666 Common Stock
Aug 17 2023
SELL
Open market or private sale
$431,800 $43.18 p/Share
10,000 Reduced 1.58%
623,666 Common Stock
Aug 17 2023
BUY
Exercise of conversion of derivative security
$138,700 $13.87 p/Share
10,000 Added 1.55%
633,666 Common Stock
Aug 16 2023
SELL
Open market or private sale
$435,300 $43.53 p/Share
10,000 Reduced 1.58%
623,666 Common Stock
Aug 16 2023
BUY
Exercise of conversion of derivative security
$138,700 $13.87 p/Share
10,000 Added 1.55%
633,666 Common Stock
Aug 15 2023
SELL
Open market or private sale
$437,700 $43.77 p/Share
10,000 Reduced 1.58%
623,666 Common Stock
Aug 15 2023
BUY
Exercise of conversion of derivative security
$138,700 $13.87 p/Share
10,000 Added 1.55%
633,666 Common Stock
Jul 27 2023
SELL
Open market or private sale
$437,900 $43.79 p/Share
10,000 Reduced 1.58%
623,666 Common Stock
Jul 27 2023
BUY
Exercise of conversion of derivative security
$138,700 $13.87 p/Share
10,000 Added 1.55%
633,666 Common Stock

Also insider at

DGX
QUEST DIAGNOSTICS INC Healthcare
Director
HT

Helen Torley

PRESIDENT AND CEO
Secaucus, NJ

Track Institutional and Insider Activities on HALO

Follow HALOZYME THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HALO shares.

Notify only if

Insider Trading

Get notified when an Halozyme Therapeutics, Inc. insider buys or sells HALO shares.

Notify only if

News

Receive news related to HALOZYME THERAPEUTICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on HALO